Experimental ALS Treatment Offers Hope for Genetic Form of Disease
Jeff Vierstra, whose family has been severely affected by ALS, is participating in an experimental treatment aimed at preventing the onset of the disease. ALS, or Amyotrophic Lateral Sclerosis, is a neurodegenerative disease that affects motor neurons, leading to loss of muscle control. Vierstra and his sisters tested positive for a genetic mutation linked to ALS. The experimental treatment, conducted at Columbia University's Eleanor and Lou Gehrig ALS Center, involves infusions targeting the mutated gene. While his sisters eventually succumbed to the disease, Vierstra has not developed ALS symptoms, suggesting the treatment may be effective in delaying or preventing the disease. 
